Preemptive pharmacologic intervention in radiation-induced salivary dysfunction

Proceedings of the Society for Experimental Biology and Medicine

Volumn 221, Issue 1, 1999, Pages 14-26

  Taylor, Samuel E ^a   Miller, Edward G ^a  

^a BAYLOR COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPRENALINE; PILOCARPINE;

ACINAR CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DNA STRAND BREAKAGE; DRUG EFFECT; NONHUMAN; PATHOPHYSIOLOGY; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RAT; SALIVARY GLAND DISEASE; SALIVARY GLAND FUNCTION; SALIVATION; SHORT SURVEY; SUBCUTANEOUS DRUG ADMINISTRATION; WELLBEING; XEROSTOMIA;

ANIMALIA;

EID: 0032927836     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1373.1999.d01-48.x     Document Type: Short Survey

References (154)

1. Longman LP, Higham SM, Bucknall R, Kaye SB, Edgar WM, Field EA. Signs and symptoms in patients with salivary gland hypofunction. Postgrad Med J 73:93-97, 1997.
2. Fox PC, van der Ven PF, Sonies BC, Weiffenbach JM, Baum BJ. Xerostomia: Evaluation of a symptom with increasing significance. J Am Dent Assoc 110:519-525, 1985.
3. Fox PC. Differentiation of dry mouth etiology. Adv Dent Res 10:13-16, 1996.
4. Pankhurst CL, Smith EC, Rogers JO, Dunne SM, Jackson SH, Proctor G. Diagnosis and management of the dry mouth: Part 1. Dental Update 23:56-62, 1996.
5. Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc 115:581-584, 1987.
6. Sreebny LM, Valdini A, Xerostomia. Part I. Relationship to other oral symptoms and salivary gland hypofunction. Oral Surg Oral Med Oral Pathol 66:451-458, 1988.
7. Sreebny LM, Valdini A, Yu A. Xerostomia. Part II. Relationship to nonoral symptoms, drugs, and diseases. Oral Surg Oral Med Oral Pathol 68:419-427, 1989.
8. Valdez IH, Fox PC. Diagnosis and management of salivary dysfunction. Crit Rev Oral Biol Med 4:271-277, 1993.
9. Garg AK, Kirsh ER. Xerostomia: Recognition and management of hypofunction of the salivary glands. Compend Contin Educ Dent 16:574, 576-584, 1995.
10. Ettinger RL. Review: Xerostomia: A symptom which acts like a disease. Age Ageing 25:409-112, 1996.
11. Greenspan D. Xerostomia: Diagnosis and management. Oncology 10:7-11, 1996.
12. Cooke C, Ahmedzai S, Mayberry J. Xerostomia - a review. Palliat Med 10:284-292, 1996.
13. Dreizen S, Daly TE, Drane JB, Brown LR. Oral complications of cancer radiotherapy. Postgrad Med 61:85-92, 1977.
14. Makkonen TA, Nordman E. Estimation of long-term salivary gland damage induced by radiotherapy. Acta Oncol 26:307-312, 1987.
15. Kashima HK, Kirkham WR, Andrews JR. Postirradiation sialadenitis. Am J Roentgenol Radium Ther Nucl Med 94:271-291, 1965.
16. Frank RM, Herdly J, Philippe E. Acquired dental defects and salivary gland lesions after irradiation for carcinoma. J Am Dent Assoc 70:878-883, 1965.
17. Franzén L, Funegård U, Ericson T, Henriksson R. Parotid gland function during and following radiotherapy of malignancies in the head and neck: A consecutive study of salivary flow and patient discomfort. Eur J Cancer 28:457-462, 1992.
18. Baum BJ, Bodner L, Fox PC, Izutsu KT, Pizzo PA, Wright WE. Therapy-induced dysfunction of salivary glands: Implications for oral health. Spec Care Dentist 5:274-277, 1985.
19. Chaushu G, Itzkovitz-Chaushu S, Yefenof E, Slavin S, Or R, Garfunkel AA. A longitudinal follow-up of salivary secretion in bone marrow transplant patients. Oral Surg Oral Med Oral Path Oral Radiol Endod 79:164-169, 1995.
20. Chaillet MP, Cosset JM, Socie G, Pico JL, Grimaud E, Dubray B, Alapetite C, Girinsky T. Prospective study of the clinical symptoms of therapeutic whole body irradiation. Health Phys 64:370-374, 1993.
21. Dens F, Boogaerts M, Boute P, Declerck D, Demuynck H, Vinckier F, Belgium B. Caries-related salivary microorganisms and salivary flow rate in bone marrow recipients. Oral Surg Oral Med Oral Path Oral Radiol Endod 81:38-43, 1996.
22. Valdez IH. Radiation-induced salivary dysfunction: clinical course and significance. Spec Care Dentist 11:252-255, 1991.
23. Valdez IH, Atkinson JC, Ship JA, Fox PC. Major salivary gland function in patients with radiation-induced xerostomia: Flow rates and sialochemistry. Int J Radiat Oncol Biol Phys 25:41-47, 1993.
24. Dreizen S, Brown LR, Handler S, Levy BM. Radiation-induced xerostomia in cancer patients: Effect on salivary and serum electrolytes. Cancer 38:273-278, 1976.
25. Brown LR, Dreizen S, Rider LJ, Johnston DA. The effect of radiation-induced xerostomia on saliva and serum lysozyme and immunoglobulin levels. Oral Surg Oral Med Oral Pathol 41:83-92, 1976.
26. Mossman KL, Shatzman AR, Chencharick JD. Effects of radiotherapy on human parotid saliva. Radiat Res 88:403-412, 1981.
27. Liu RP, Fleming TJ, Toth BB, Keene HJ. Salivary flow rates in patients with head and neck cancer 0.5 to 25 years after radiotherapy. Oral Surg Oral Med Oral Pathol 70:724-729, 1990.
28. Leslie MD, Dische S. Parotid gland function following accelerated and conventionally fractionated radiotherapy. Radiother Oncol 22:133-139, 1991.
29. Marks JE, Davis CC, Gottsman VL, Purdy JE, Lee F. The effects of radiation on parotid salivary function. Int J Radiat Oncol Biol Phys 7:1013-1019, 1981.
30. Mira JG, Wescott WB, Starcke EN, Shannon IL. Some factors influencing salivary function when treating with radiotherapy. Int J Radiat Oncol Biol Phys 7:535-541, 1981.
31. Mira JG, Fullerton GD, Wescott WB. Correlation between initial salivary flow rate and radiation dose in the production of xerostomia. Acta Radiol Oncol 21:151-154, 1982.
32. LeVeque FG, Montgomery M, Potter D, Zimmer MB, Rieke JW, Steiger BW, Gallagher SC, Muscoplat CC. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol 11:1124-1131, 1993.
33. Valdez IH, Wolff A, Atkinson JC, Macynski AA, Fox PC. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction. Cancer 71:1848-1851, 1993.
34. Johnson JT, Ferretti GA, Nethery WJ, Valdez IH, Fox PC, Ng D, Muscoplat CC, Gallagher SC. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. New Engl J Med 329:390-395, 1993.
35. Fox PC. Management of dry mouth. Dental Clinics North Am 41:863-875, 1997.
36. Fox PC, Atkinson JC, Macynski AA, Wolff A, Kung DS, Valdez IH, Jackson W, Delapenha RA, Shiroky J, Baum BJ. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch Intern Med 151:1149-1152, 1991.
37. Garg AK, Malo M. Manifestations and treatment of xerostomia and associated oral effects secondary to head and neck radiation therapy. J Am Dent Assoc 128:1128-1133, 1997.
38. Guchelaar HJ, Vermes A, Meerwaldt JH. Radiation-induced xerostomia: Pathophysiology, clinical course and supportive treatment. Support Care Cancer 5:281-288, 1997.
39. Madeya ML. Oral complications from cancer therapy: Part 1-Pathophystology and secondary complications. Oncol Nurs Forum 23:801-807, 1996.
40. Hillman JD. Principles of microbial ecology and their application to xerostomia-associated opportunistic infections of the oral cavity. Adv Dent Res 10:66-68, 1996.
41. Iwamoto RR. A nursing perspective on radiation-induced xerostomia. Oncology 10:12-15, 1996.
42. Wolff A, Fox PC, Ship JA, Atkinson JC, Macynski AA, Baum BJ. Oral mucosal status and major salivary gland function. Oral Surg Oral Med Oral Pathol 70:49-54, 1990.
43. Dose AM. The symptom experience of mucositis, stomatitis, and xerostomia. Semin Oncol Nurs 11:248-255, 1995.
44. Rhodus NL, Moller K, Colby S, Bereuter J. Dysphagia in patients with three different etiologies of salivary gland dysfunction. Ear Nose Throat J 74:39-42, 45-48, 1995.
45. Backstrom I, Funegard U, Andersson I, Franzen L, Johansson I. Dietary intake in head and neck irradiated patients with permanent dry mouth symptoms. Eur J Cancer B Oral Oncol 316:253-257, 1995.
46. Hamlet S, Faull J, Klein B, Aref A, Fontanesi J, Stachler R, Shamsa F, Jones L, Simpson M. Mastication and swallowing in patients with postirradiation xerostomia. Int J Radiat Oncol Biol Phys 37:789-796, 1997.
47. Rhodus NL, Moller K, Colby S, Bereuter J. Articulatory speech performance in patients with salivary gland dysfunction: A pilot study. Quintessence Int 26:805-810, 1995.
48. Ramirez-Amador V, Silverman S Jr, Mayer P, Tyler M, Quivey J. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. Oral Surg Oral Med Oral Path Oral Radiol Endod 84:149-153, 1997.
49. Evans JC, Ackerman LV. Irradiated and obstructed submaxillary salivary glands simulating cervical lymph node metastasis. Radiology 62:550-554, 1954.
50. Cooper JS, Fu K, Marks J, Silverman S. Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys 31:1141-1164, 1995.
51. Tsujii H. Quantitative dose-response analysis of salivary function following radiotherapy using sequential RI-sialography. Int J Radiat Oncol Biol Phys 11:1603-1612, 1985.
52. Nagler RM. Short- and long-term functional vs morphometrical salivary effects of irradiation in a rodent model. Anticancer Res 18:315-320, 1998.
53. Vissink A, 's-Gravenmade EJ, Ligeon EE, Konings WT. A functional and chemical study of radiation effects on rat parotid and submandibular/sublingual glands. Radiat Res 124:259-265, 1990.
54. Vissink A, Konings AW, Ligeon EE, 's-Gravenmade EJ. Irradiation-induced changes in secretion and composition of rat saliva. J Biol Buccale 18:3-8, 1990.
55. Vissink A, Kalicharan D, 's-Gravenmade EJ, Jongebloed WL, Ligeon EE, Nieuwenhuis P, Konings AWT. Acute irradiation effects on morphology and function of rat submandibular glands. J Oral Pathol Med 20:449-156, 1991.
56. Nagler RM, Baum BJ, Fox PC. Effects of X irradiation on the function of rat salivary glands at 3 and 40 days. Radiat Res 136:392-396, 1993.
57. Nagler RM, Baum BJ, Fox PC. Acute effects of X irradiation on the function of rat salivary glands. Radiat Res 136:42-47, 1993.
58. Nagler RM, Baum BJ, Fox PC. A 2-week pair-fed study of early X-irradiation effects on rat major salivary gland function. Arch Oral Biol 41:713-717, 1996.
59. Nagler RM, Baum BJ, Miller G, Fox PC. Long-term salivary effects of single-dose head and neck irradiation in the rat. Arch Oral Biol 43:297-303, 1998.
60. Savage NW, Adkins KF, Kruger BJ. The effects of fractionated megavoltage X-irradiation on the rat submandibular gland: an assessment by light microscopy and autoradiography. Aust Dent J 30:1-7, 1985.
61. Savage NW, Kruger BJ, Adkins KF. The effects of fractionated megavoltage X-irradiation on rat submandibular gland: An assessment by electron microscopy. Aust Dent J 30:188-193, 1985.
62. Sodicoff M, Pratt NE, Sholley MM. Ultrastructural radiation injury of rat parotid gland: A histopathologic dose-response study. Radiat Res 58:196-208, 1974.
63. Sholley MM, Sodicoff M, Pratt NE. Early radiation injury in the rat parotid gland: Reaction of acinar cells and vascular endothelium. Lab Invest 31:340-354, 1974.
64. Ahlner BH, Hagelqvist E, Lind MG, Ruden BI. Irradiation of rabbit submandibular glands: Histology and morphometry after 15 Gy. Acta Otolaryngol (Stockh) 113:210-219, 1993.
65. Ahlner BH, Hagelqvist E, Lind MG. Influence on rabbit submandibular gland injury by stimulation or inhibition of gland function during irradiation: Histology and morphometry after 15 gray. Ann Otol Rhinol Laryngol 103:125-134, 1994.
66. Stephens LC, King GK, Peters LJ, Ang KK, Schultheiss TE, Jardine JH. Unique radiosensitivity of serous cells in rhesus monkey submandibular glands. Am J Pathol 124:479-187, 1986.
67. Stephens LC, King GK, Peters LJ, Ang KK, Schultheiss TE, Jardine JH. Acute and late radiation injury in rhesus monkey parotid glands. Evidence of interphase cell death. Am J Pathol 124:469-178, 1986.
68. Stephens LC, Ang KK, Schultheiss TE, King GK, Brock WA, Peters LJ. Target cell and mode of radiation injury in rhesus salivary glands. Radiother Oncol 7:165-174, 1986.
69. Stephens LC, Schultheiss TE, Price RE, Ang KK, Peters LJ. Radiation apoptosis of serous acinar cells of salivary and lacrimal glands. Cancer 67:1539-1543, 1991.
70. Nagler RM, Laufer D. Protection against irradiation-induced damage to salivary glands by adrenergic agonist administration. Int J Radiat Oncol Biol Phys 40:477-481, 1998.
71. Stephens LC, Schultheiss TE, Small SM, Ang KK, Peters LJ. Response of parotid gland organ culture to radiation. Radiat Res 120:140-153, 1989.
72. Vissink A, 's-Gravenmade EJ, Ligeon EE, Konings AW. Effects of split-dose X-irradiation on rat salivary gland function. Radiat Res 127:52-57, 1991.
73. Vissink A, Down JD, Konings AWT. Contrasting dose-rate effects of τ-irradiation on rat salivary gland function. Int J Radiat Biol 61:275-282, 1992.
74. Stephens LC, Ang KK, Schultheiss TE, Milas L, Meyn RE. Apoptosis in irradiated murine tumors. Radiat Res 127:308-316, 1991.
75. Payne CM, Bernstein C, Bernstein H. Apoptosis overview emphasizing the role of oxidative stress, DNA damage and signal-transduction pathways. Leuk Lymphoma 19:43-93, 1995.
76. Schwartz-Arad D, Arber L, Arber N, Zajicek G, Michaeli Y. The rat parotid gland: A renewing cell population. J Anat 161:143-151, 1988.
77. Zajicek G, Yagil C, Michaeli Y. The streaming submandibular gland. Anat Rec 213:150-158, 1985.
78. Denny PC, Chai Y, Klauser DK, Denny PA. Parenchymal cell proliferation and mechanisms for maintenance of granular duct and acinar cell populations in adult male mouse submandibular gland. Anat Rec 235:475-185, 1993.
79. Ballagh RH, Kudryk KG, Lampe HB, Moriarty B, Mackay A, Burford-Mason AP, Dardick I. The pathobiology of salivary gland. III. PCNA-localization of cycling cells induced in rat submandibular gland by low-dose x-radiation. Oral Surg Oral Med Oral Pathol 77:27-35, 1994.
80. Peter B, Van Waarde MA, Vissink A, 's-Gravenmade EJ, Konings AW. Radiation-induced cell proliferation in the parotid and submandibular glands of the rat. Radiat Res 140:257-265, 1994.
81. Datta R, Kharbanda S, Kufe D. Regulation of jun-B gene expression by 1-β-d-arabinofuranosyl-cytosine in human myeloid leukemia cells. Mol Pharmacol 38:435-439, 1990.
82. Mertz PM, Fox PC, Pluta A, Baum BJ, Kousvelari EE. Effects of ionizing radiation and β-adrenergic stimulation on the expression of early response genes in rat parotid glands. Radiat Res 130:104-112, 1992.
83. Nagler RM, Nagler A. Effects of ionizing irradiation and β-adrenergic stimulation on gene expression pattern in rat submandibular glands. Anticancer Res 16:2749-2756, 1996.
84. Bodner L, Kuyatt BL, Hand AR, Baum BJ. Rat parotid cell function in vitro following X-irradiation in vivo. Radiat Res 97:386-395, 1984.
85. Franzén L, Funegård U, Sundström S, Gustafsson H, Danielsson A, Henriksson R. Fractionated irradiation and early changes in salivary glands: Different effects on potassium efflux, exocytotic amylase release and gland morphology. Lab Invest 64:279-283, 1991.
86. Franzén L, Sundström S, Karlsson M, Gustafsson H, Littbrand B, Henriksson R. Fractionated irradiation and early changes in noradrenaline induced potassium efflux (86Rb+) in rat parotid gland. Acta Oncol 31:359-364, 1992.
87. Franzén L, Gustafsson H, Sundström S, Karlsson M, Littbrand B, Henriksson R. Fractionated irradiation and late changes in rat parotid gland: effects on the number of acinar cells, potassium efflux, and amylase secretion. Int J Radiat Biol 64:93-101, 1993.
88. Taylor SE, Haghighat NG, Holmes-Marshall J, Sokolowski T, Wright J, Al-Hashimi I. Effect of radiation on mucin secretion by rat submandibular gland. J Dent Res 75:99, 1997.
89. Bodner L. Transport of α-aminoisobutyric acid into rat parotid after X-irradiation. Int J Radiat Biol 55:653-660, 1989.
90. Savage NW, Kruger BJ, Adkins KF. Rat submandibular gland microvasculature following fractionated megavoltage irradiation. Aust Dent J 30:99-103, 1985.
91. Hiramatsu Y, Nagler RM, Fox PC, Baum BJ. Rat salivary gland blood flow and blood-to-tissue partition coefficients following X-irradiation. Arch Oral Biol 39:77-80, 1994.
92. Ahlner BH, Jogestrand T, Lind MG, Lund F. Blood flow through irradiated rabbit submandibular glands measured with fluorescein angiography. Eur Arch Otorhinolaryngol 249:459-461, 1993.
93. Kohn WG, Grossman E, Fox PC, Armando I, Goldstein DS, Baum BJ. Effect of ionizing radiation on sympathetic nerve function in rat parotid glands. J Oral Pathol Med 21:134-137, 1992.
94. Forsgren S, Franzén L, Funegård U, Gustafsson H, Henriksson R. Bilateral irradiation of head and neck induces an enhanced expression of substance-P in the parasympathetic innervation of the submandibular gland. Neuroscience 46:233-240, 1992.
95. Baum BJ, Hiramatsu Y, Kohn WG, Valdez IH. New approaches for determining the site of salivary fluid secretory disorders. Adv Dent Res 7:220-224, 1993.
96. Turner RJ, Paulais M, Manganel M, Lee SI, Moran A, Melvin JE. Ion and water transport mechanisms in salivary glands. Crit Rev Oral Biol Med 4:385-391, 1993.
97. O'Connell AC, Redman R, Evans RL, Ambudkar IS. Radiation-induced progressive decrease in fluid secretion in rat submandibular glands is related to decreased acinar volume and not impaired calcium signaling. Radiat Res 151:150-158, 1999.
98. O'Connell AC, Lillibridge CD, Zheng C, Baum BJ, O'Connell BC, Ambudkar IS. γ-Irradiation-induced cell cycle arrest and cell death in the human submandibular gland cell line: Effect of E2F1 expression. J Cell Physiol 177:264-273, 1998.
99. Funegård U, Johansson I, Franzén L, Ericson T, Nyström H, Henriksson R. Rat salivary gland function after fractionated irradiation. Acta Oncol 36:191-198, 1997.
100. Eneström S, Norberg L, Lundquist PG. Radiation-induced decreases of serous cell immunoglobulin excretions in the rat submandibular gland. Arch Otorhinolaryngol 245:122-126, 1988.
101. Singh A, Singh H. Time-scale and nature of radiation-biological damage: Approaches to radiation protection and post-irradiation therapy. Prog Biophys Mol Biol 39:69-107, 1982.
102. Jones JB, Cramer HM, Inch WR, Lampe HB. Radioprotective effect of free radical scavenging enzymes. J Otolaryngol 19:299-306, 1990.
103. Hall EJ, Cox JD. Physical and biologic basis of radiation therapy. In: Cox JD, Ed. Moss' Radiation Oncology: Rationale, Technique, Results (7th ed). St. Louis: Mosby, pp3-66, 1994.
104. McCord JM. Oxygen-derived free radicals. New Horizons 1:70-76, 1993.
105. Arima R, Shiba R. Radioprotective effect of exogenous glutathione on rat parotid glands. Int J Radiat Biol 61:695-702, 1992.
106. Sodicoff M, Conger AD, Pratt NE. Isoproterenol in comparison to WR-2721 as a chemoradioprotector of the rat parotid gland. Invest Radiol 14:166-170, 1979.
107. Sodicoff M, Conger AD. Radioprotection of the rat parotid gland by WR-2721 and isoproterenol and its modification by propranolol. Radiat Res 94:97-104, 1983.
108. Whitson SW, Hand AR. Isoproterenol-induced changes in glutathione metabolism in the rat parotid gland. Arch Oral Biol 29:137-140, 1984.
109. Yuhas JM, Proctor JO, Smith LH. Some pharmacologic effects of WR-2721: Their role in toxicity and radioprotection. Radiat Res 54:222-233, 1973.
110. Yuhas JM. Radiotherapy of experimental lung tumors in the presence and absence of a radioprotective drug, S-2-(3-aminopropylamino) ethylphosphorothioic acid (WR-2721). J Natl Cancer Inst 50:69-78, 1973.
111. Yuhas JM, Spellman JM, Culo F. The role of WR-2721 in radiotherapy and/or chemotherapy. Cancer Clin Trials 3:211-216, 1980.
112. Conger AD, Sodicoff M, Samel A. Comparison of cAMP with other radioprotectors against chronic damage to the rat parotid gland. Radiat Res 102:99-105, 1985.
113. Wasserman TH. Radiotherapeutic studies with amifostine (Ethyol). Semin Oncol 21:21-25, 1994.
114. Peters GJ, van der Vijgh WJ. Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (WR-2721): Preclinical aspects. Eur J Cancer 31 (Suppl 1):S1-S7, 1995.
115. Yuhas JM. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino) - ethylphosphorothioic acid. Cancer Res 40:1519-1524, 1980.
116. Utley JF, Marlowe C, Waddell WJ. Distribution of 35S-labeled WR-2721 in normal and malignant tissues of the mouse. Radiat Res 68:284-291, 1976.
117. Abok K, Brunk U, Jung B, Ericsson J. Morphologic and histochemical studies on the differing radiosensitivity of ductular and acinar cells of the rat submandibular gland. Virchows Arch B, Cell Pathol Incl Mol Pathol 45:443-460, 1984.
118. Peter B, Van Waarde MA, Vissink A, 's-Gravenmade EJ, Konings AW. Degranulation of rat salivary glands following treatment with receptor-selective agonists. Clin Exp Pharmacol Physiol 22:330-336, 1995.
119. Lundquist PG, Norberg LE. Salivary gland morphology after α-adrenergic and cholinergic stimulation: An ultrastructural study. Acta Otolaryngol Suppl (Stockh) 447:14-22, 1988.
120. Lundquist PG, Norberg L. Morphological changes in salivary glands after treatment with sialagogues: An electronmicroscopical study. Acta Otolaryngol (Stockh) 107:434-440, 1989.
121. Gemryd P, Norberg LE, Lundquist PG. Studies on the regranulation of salivary gland serous cells: An electron microscopical study in the rat. ORL J Otorhinolaryngol Relat Spec 54:33-37, 1992.
122. Norberg LE, Forsberg-B. α-Adrenergic stimulation and radiosensitivity on the rat submaxillary gland. ORL J Otorhinolaryngol Relat Spec 49:302-313, 1987.
123. Norberg LE, Lundquist PG. An ultrastructural study of salivary gland radiosensitivity after alpha-adrenergic stimulation. Auris Nasus Larynx 15:1-17, 1988.
124. Norberg LE, Lundquist PG. Aspects of salivary gland radiosensitivity: Effects of sialagogues and irradiation. Arch Otorhinolaryngol 246:200-204, 1989.
125. Lotz S, Caselitz J, Tschakert H, Rehpenning W, Seifert G. Radioprotection of minipig salivary glands by orciprenaline-carbachol: An ultrastructural and semiquantitative light microscopic study. Virchows Arch A (Pathol Anat Histopathol) 417:119-128, 1990.
126. Kim KH, Kim JY, Sung MW, Kim CW. The effect of pilocarpine and atropine administration on radiation-induced injury of rat submandibular glands. Acta Otolaryngol (Stockh) 111:967-973, 1991.
127. Norberg LE, Abok K, Lundquist PG. Effects of ligation and irradiation on the submaxillary glands in rats. Acta Otolaryngol (Stockh) 105:181-192, 1988.
128. Nagler R, Marmary Y, Fox PC, Baum BJ, Har-El R, Chevion M. Irradiation-induced damage to the salivary glands: The role of redox-active iron and copper. Radiat Res 147:468-476, 1997.
129. Nagler R, Marmary Y, Golan E, Chevion M. Novel protection strategy against X-ray-induced damage to salivary glands. Radiat Res 149:271-276, 1998.
130. Peter B, Van Waarde MA, Vissink A, 's-Gravenmade EJ, Konings AW. The role of secretory granules in the radiosensitivity of rat salivary gland acini: A morphological study. Radiat Res 140:419-428, 1994.
131. Peter B, Van Waarde MA, Vissink A, 's-Gravenmade EJ, Konings AW. The role of secretory granules in radiation-induced dysfunction of rat salivary glands. Radiat Res 141:176-182, 1995.
132. Coppes RP, Vissink A, Zeilstra LJ, Konings AW. Muscarinic receptor stimulation increases tolerance of rat salivary gland function to radiation damage. Int J Radiat Biol 72:615-625, 1997.
133. Coppes RP, Zeilstra LJ, Vissink A, Konings AW. Sialogogue-related radioprotection of salivary gland function: The degranulation concept revisited. Radiat Res 148:240-247, 1997.
134. Selye H, Veilleux R, Cantin M. Excessive stimulation of salivary gland growth by isoproterenol. Science 133:44-45, 1961.
135. Schneyer CA. β-Adrenergic effects by autonomic agents on mitosis and hypertrophy in rat parotid. Proc Soc Exp Biol Med 131:71-75, 1969.
136. Van den Brenk H.A, Stone MG. Effect of X-radiation on salivary gland growth in the rat. IV. Relative effects of local irradiation on growth, regressive and secretory phases of sialadenotrophism. Int J Radiat Biol 22:205-223, 1972.
137. Schneyer CA, Finn RJ Jr., Phillips RM. Modification of irradiation effects on rat parotid by chronic pretreatment with isoproterernol. Proc Soc Exp Biol Med 131:723-727, 1969.
138. Hall HD. Role of isoproterenol in radioprotection against acute changes in the rat parotid gland. J Oral Surg 32:665-670, 1974.
139. Sodicoff M, Conger AD. Radioprotection of the rat parotid gland by cAMP. Radiat Res 96:90-94, 1983.
140. Caranasos GJ, Stewart RB, Cluff LE. Clinically desirable drug interactions. In: George R, Ed. Annual Review of Pharmacology and Toxicology. Palo Alto, CA: Annual Reviews Inc., Vol 25:pp67-95, 1985.
141. Berenbaum MC. What is synergy? Pharmacol Rev 41:93-141, 1989.
142. Gessner PK. A straightforward method for the study of drug interactions: An isobolographic analysis primer. J Am Coll Toxicol 7:987-1012, 1988.
143. Takemura H. Inhibitory effect of carbachol on isoproterenol-induced amylase release from isolated rat parotid cells. Jpn J Pharmacol 35:9-17, 1984.
144. Takemura H. Potentiation of amylase release from isolated rat parotid cells: Studies on the combination of isoproterenol and a low dose of carbachol. Jpn J Pharmacol 36:107-109, 1984.
145. McDonald S, Meyerowitz C, Smudzin T, Rubin P. Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction. Int J Radiat Oncol Biol Phys 29:747-754, 1994.
146. Wolff A, Atkinson JC, Macynski AA, Fox PC. Oral complications of cancer therapies: Pretherapy interventions to modify salivary dysfunction. NCI Monogr 9:87-90, 1990.
147. D'Hondt E, Eisbruch A, Ship JA. The influence of pre-radiation salivary flow rates and radiation dose on parotid salivary gland dysfunction in patients receiving radiotherapy for head and neck cancers. Spec Care Dentist 18:102-108, 1998.
148. Zimmerman RP, Mark RJ, Tran LM, Juillard GF. Concomitant pilocarpine during head and neck irradiation is associated with decreased post-treatment xerostomia. Int J Radiat Oncol Biol Phys 37:571-575, 1997.
149. Eisbruch A, Ship JA, Martel MK, Ten Haken RK, Marsh LH, Wolf GT, Esclamado RM, Bradford CR, Terrell JE, Gebarski SS, Lichter AS. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: Techniques and early results. Int J Radiat Oncol Biol Phys 36:469-480, 1996.
150. Ship JA, Eisbruch A, D'Hondt E, Jones RE. Parotid sparing study in head and neck cancer patients receiving bilateral radiation therapy: One-year results. J Dent Res 76:807-813, 1997.
151. Nishioka T, Shirato H, Arimoto T, Kaneko M, Kitahara T, Oomori K, Yasuda M, Fukuda S, Inuyama Y, Miyasaka K. Reduction of radiation-induced xerostomia in nasopharyngeal carcinoma using CT simulation with laser patient marking and three-field irradiation technique. Int J Radiat Oncol Biol Phys 38:705-712, 1997.
152. Eisbruch A, Marsh LH, Martel MK, Ship JA, Ten Haken R, Pu AT, Fraass BA, Lichter AS. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: Assessment of target coverage and noninvolved tissue sparing. Int J Radiat Oncol Biol Phys 41:559-568, 1998.
153. Delporte C, O'Connell BC, He X, Ambudkar IS, Agre P, Baum BJ. Adenovirus-mediated expression of aquaporin-5 in epithelial cells. J Biol Chem 271:22070-22075, 1996.
154. Delporte C, O'Connell BC, He X, Lancaster HE, O'Connell AC, Agre P, Baum BJ. Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands. Proc Natl Acad Sci U S A 94:3268-3273, 1997.